Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...
Stocktwits on MSN
Genmab stock slips after discontinuing further development of cancer drug developed with BioNTech
The decision to discontinue further clinical development of Acasunlimab does not impact Genmab’s full‑year 2025 financial ...
13don MSN
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer
Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...
The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...
New clinical evidence indicates that a widely used supplement may alter gut microbes involved in vitamin D biology and ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...
15don MSN
Cracking the code of a hidden cancer receptor: How scientists found the first true Frizzled blocker
Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family linked to cancer development. The findings have been published in Nature ...
Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback